4//SEC Filing
Oxtoby Andrew 4
Accession 0000899243-20-008621
CIK 0001631650other
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 4:51 PM ET
Size
5.8 KB
Accession
0000899243-20-008621
Insider Transaction Report
Form 4
Oxtoby Andrew
Chief Commercial Officer
Transactions
- Purchase
Common Stock, $0.0001 par value
2020-03-13$14.76/sh+3,000$44,266→ 25,015 total
Footnotes (3)
- [F1]Represents the weighted average purchase price for the entire number of shares purchased. The actual purchase prices range from $14.5450 to $14.8500 per share. Information on the exact number of shares purchased at each purchase price can be obtained from the Issuer upon request.
- [F2]Includes 11,250 restricted stock units ("RSUs") and will be settled in common stock upon vesting. The RSUs vest in three successive, equal, annual installments measured from March 1, 2020, subject to the Reporting Person's continued service relationship with the Issuer on each such vesting date
- [F3]Includes 9,000 RSUs and will be settled in common stock upon vesting. The RSUs vest in four successive, equal, annual installments measured from January 19, 2019 subject to the Reporting Person's continued service relationship with the Issuer on each such vesting date.
Documents
Issuer
Aimmune Therapeutics, Inc.
CIK 0001631650
Entity typeother
Related Parties
1- filerCIK 0001765473
Filing Metadata
- Form type
- 4
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 4:51 PM ET
- Size
- 5.8 KB